HERON THERAPEUTICS, INC. /DE/ Increase (Decrease) in Employee Related Liabilities
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Increase (Decrease) in Employee Related Liabilities of -$2.64 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2026-08-10
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in employee related liabilities for the quarter ending 2026-06-30 was $242.00K, a 1110.00% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in employee related liabilities for the quarter ending 2026-03-31 was -$2.88M.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in employee related liabilities for the quarter ending 2025-12-31 was $522.00K, a 48.97% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in employee related liabilities for the quarter ending 2025-09-30 was $2.28M, a 57.47% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in employee related liabilities for fiscal 2025 was -$284.00K, a 186.06% decline from fiscal 2024.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in employee related liabilities for fiscal 2024 was $330.00K.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in employee related liabilities for fiscal 2023 was -$4.19M.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in employee related liabilities for fiscal 2022 was -$1.85M, a 210.86% decline from fiscal 2021.
| Period end | Increase (Decrease) in Employee Related Liabilities 3 month | Increase (Decrease) in Employee Related Liabilities 6 month | Increase (Decrease) in Employee Related Liabilities 9 month | Increase (Decrease) in Employee Related Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $242.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$2.64M 10-Q · filed 2026-08-10 | -$2.12M derived: sum of 3 quarters · filed 2026-08-10 | $161.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$2.88M 10-Q · filed 2026-05-11 | -$2.36M derived: sum of 2 quarters · filed 2026-05-11 | -$81.00K derived: sum of 3 quarters · filed 2026-05-11 | -$61.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $522.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.80M derived: sum of 2 quarters · filed 2026-02-26 | $2.82M derived: sum of 3 quarters · filed 2026-08-10 | -$284.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.30M derived: sum of 2 quarters · filed 2026-08-10 | -$806.00K 10-Q · filed 2025-11-04 | $217.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$3.08M 10-Q · filed 2026-08-10 | -$2.06M derived: sum of 3 quarters · filed 2026-08-10 | -$614.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$3.10M 10-Q · filed 2026-05-11 | -$2.08M derived: sum of 2 quarters · filed 2026-05-11 | -$634.00K derived: sum of 3 quarters · filed 2026-05-11 | -$1.20M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.47M derived: sum of 2 quarters · filed 2026-02-26 | $1.91M derived: sum of 3 quarters · filed 2026-02-26 | $330.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $884.00K derived: sum of 2 quarters · filed 2025-11-04 | -$693.00K 10-Q · filed 2025-11-04 | -$1.84M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$562.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$2.14M 10-Q · filed 2025-08-08 | -$3.29M derived: sum of 3 quarters · filed 2026-02-26 | -$2.77M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$1.58M 10-Q · filed 2025-05-06 | -$2.73M derived: sum of 2 quarters · filed 2026-02-26 | -$2.21M derived: sum of 3 quarters · filed 2026-02-26 | -$1.86M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$632.00K derived: sum of 2 quarters · filed 2026-02-26 | -$286.00K derived: sum of 3 quarters · filed 2026-02-26 | -$4.19M 10-K · filed 2026-02-26 |
| 2023-09-30 | $520.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $866.00K derived: sum of 2 quarters · filed 2024-11-12 | -$3.04M 10-Q · filed 2024-11-12 | -$4.33M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $346.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$3.56M 10-Q · filed 2024-08-06 | -$4.85M derived: sum of 3 quarters · filed 2025-02-27 | -$6.47M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$3.91M 10-Q · filed 2024-05-07 | -$5.20M derived: sum of 2 quarters · filed 2025-02-27 | -$6.81M derived: sum of 3 quarters · filed 2025-02-27 | -$2.70M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$2.91M derived: sum of 2 quarters · filed 2025-02-27 | $1.20M derived: sum of 3 quarters · filed 2025-02-27 | -$1.85M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $2.49M derived: sum of 2 quarters · filed 2023-11-14 | -$555.00K 10-Q · filed 2023-11-14 | -$1.30M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $4.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.06M 10-Q · filed 2023-08-14 | $317.00K derived: sum of 3 quarters · filed 2023-08-14 | $2.64M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$3.05M 10-Q · filed 2023-05-11 | -$3.79M derived: sum of 2 quarters · filed 2023-05-11 | -$1.47M derived: sum of 3 quarters · filed 2023-05-11 | $2.58M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$743.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $1.58M derived: sum of 2 quarters · filed 2023-03-29 | $5.63M derived: sum of 3 quarters · filed 2023-03-29 | $1.67M 10-K · filed 2023-03-29 |
| 2021-09-30 | $2.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $6.38M derived: sum of 2 quarters · filed 2022-11-08 | $2.41M 10-Q · filed 2022-11-08 | $2.77M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $4.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $84.00K 10-Q · filed 2022-08-09 | $446.00K derived: sum of 3 quarters · filed 2022-08-09 | $2.49M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$3.97M 10-Q · filed 2022-05-09 | -$3.61M derived: sum of 2 quarters · filed 2022-05-09 | -$1.56M derived: sum of 3 quarters · filed 2022-05-09 | $859.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $362.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $2.40M derived: sum of 2 quarters · filed 2022-02-28 | $4.83M derived: sum of 3 quarters · filed 2022-02-28 | -$1.65M 10-K · filed 2022-02-28 |
| 2020-09-30 | $2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $4.46M derived: sum of 2 quarters · filed 2021-11-03 | -$2.01M 10-Q · filed 2021-11-03 | $3.10M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $2.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$4.05M 10-Q · filed 2021-08-09 | $1.06M derived: sum of 3 quarters · filed 2022-02-28 | $2.21M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$6.48M 10-Q · filed 2021-05-10 | -$1.36M derived: sum of 2 quarters · filed 2022-02-28 | -$212.00K derived: sum of 3 quarters · filed 2022-02-28 | $2.13M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $5.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $6.27M derived: sum of 2 quarters · filed 2022-02-28 | $8.61M derived: sum of 3 quarters · filed 2022-02-28 | $1.85M 10-K · filed 2022-02-28 |
| 2019-09-30 | $1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $3.49M derived: sum of 2 quarters · filed 2020-11-05 | -$3.26M 10-Q · filed 2020-11-05 | $1.68M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $2.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$4.42M 10-Q · filed 2020-08-05 | $525.00K derived: sum of 3 quarters · filed 2021-02-24 | $2.10M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | -$6.76M 10-Q · filed 2020-05-06 | -$1.82M derived: sum of 2 quarters · filed 2021-02-24 | -$246.00K derived: sum of 3 quarters · filed 2021-02-24 | $1.39M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $4.94M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $6.51M derived: sum of 2 quarters · filed 2021-02-24 | $8.15M derived: sum of 3 quarters · filed 2021-02-24 | $4.54M 10-K · filed 2021-02-24 |
| 2018-09-30 | $1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $3.21M derived: sum of 2 quarters · filed 2019-11-12 | -$403.00K 10-Q · filed 2019-11-12 | $607.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | -$1.97M 10-Q · filed 2019-08-05 | -$964.00K derived: sum of 3 quarters · filed 2020-03-02 | -$372.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | -$3.61M 10-Q · filed 2019-05-09 | -$2.60M derived: sum of 2 quarters · filed 2020-03-02 | -$2.01M derived: sum of 3 quarters · filed 2020-03-02 | -$874.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $1.60M derived: sum of 2 quarters · filed 2020-03-02 | $2.74M derived: sum of 3 quarters · filed 2020-03-02 | $446.00K 10-K · filed 2020-03-02 |
| 2017-09-30 | $592.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $1.73M derived: sum of 2 quarters · filed 2018-11-07 | -$564.00K 10-Q · filed 2018-11-07 | -$791.00K derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$1.16M 10-Q · filed 2018-08-08 | -$1.38M derived: sum of 3 quarters · filed 2019-02-22 | $2.58M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-03-31 | -$2.29M 10-Q · filed 2018-05-10 | -$2.52M derived: sum of 2 quarters · filed 2019-02-22 | $1.45M derived: sum of 3 quarters · filed 2019-02-22 | $3.15M derived: sum of 4 quarters · filed 2019-02-22 |
| 2016-12-31 | -$227.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $3.74M derived: sum of 2 quarters · filed 2019-02-22 | $5.45M derived: sum of 3 quarters · filed 2019-02-22 | $3.59M 10-K · filed 2019-02-22 |
| 2016-09-30 | $3.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $5.67M derived: sum of 2 quarters · filed 2017-11-06 | $3.81M 10-Q · filed 2017-11-06 | $5.25M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$154.00K 10-Q · filed 2017-08-09 | $1.28M derived: sum of 3 quarters · filed 2018-02-27 | $2.39M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | -$1.86M 10-Q · filed 2017-05-10 | -$420.00K derived: sum of 2 quarters · filed 2018-02-27 | $685.00K derived: sum of 3 quarters · filed 2018-02-27 | $1.31M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $2.54M derived: sum of 2 quarters · filed 2018-02-27 | $3.17M derived: sum of 3 quarters · filed 2018-02-27 | $2.10M 10-K · filed 2018-02-27 |
| 2015-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $1.73M derived: sum of 2 quarters · filed 2016-11-08 | $658.00K 10-Q · filed 2016-11-08 | $788.00K derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $628.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$447.00K 10-Q · filed 2016-08-08 | -$317.00K derived: sum of 3 quarters · filed 2017-02-23 | $449.00K derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | -$1.07M 10-Q · filed 2016-05-05 | -$945.00K derived: sum of 2 quarters · filed 2017-02-23 | -$179.00K derived: sum of 3 quarters · filed 2017-02-23 | $344.00K derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $896.00K derived: sum of 2 quarters · filed 2017-02-23 | $1.42M derived: sum of 3 quarters · filed 2017-02-23 | $165.00K 10-K · filed 2017-02-23 |
| 2014-09-30 | $766.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $1.29M derived: sum of 2 quarters · filed 2015-11-06 | $35.00K 10-Q · filed 2015-11-06 | $1.73M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | $523.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$731.00K 10-Q · filed 2015-08-07 | $968.00K derived: sum of 3 quarters · filed 2016-02-19 | $1.53M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | -$1.25M 10-Q · filed 2015-05-08 | $445.00K derived: sum of 2 quarters · filed 2016-02-19 | $1.01M derived: sum of 3 quarters · filed 2016-02-19 | |
| 2013-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $2.26M derived: sum of 2 quarters · filed 2016-02-19 | $2.15M 10-K · filed 2016-02-19 | |
| 2013-09-30 | $564.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $454.00K 10-Q · filed 2014-11-06 | ||
| 2013-06-30 | -$110.00K 10-Q · filed 2014-08-04 | |||
| 2012-12-31 | -$149.00K 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |